New Key Statistics Module, Z-Score and F-Score
NAS:UTHR Key Ratios
Market Cap $ M | 16,540.35 |
Enterprise Value $ M | 13,613.85 |
P/E(ttm) | 16.27 |
PE Ratio without NRI | 15.54 |
Forward PE Ratio | 13.29 |
Price/Book | 2.71 |
Price/Sales | 6.56 |
Price/Free Cash Flow | 20.14 |
Price/Owner Earnings | 19.64 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 2,756.00 |
EPS (TTM) $ | 22.77 |
Beneish M-Score | -2.18 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 24.50 |
EV-to-EBIT | 9.15 |
EV-to-EBITDA | 8.76 |
PEG | -- |
Shares Outstanding M | 44.64 |
Net Margin (%) | 40.31 |
Operating Margin % | 48.78 |
Pre-tax Margin (%) | 52.17 |
Quick Ratio | 4.41 |
Current Ratio | 4.58 |
ROA % (ttm) | 16.09 |
ROE % (ttm) | 19.26 |
ROIC % (ttm) | 27.13 |
Dividend Yield % | -- |
Altman Z-Score | 12.67 |
UTHR Number of Guru Trades
UTHR Volume of Guru Trades
Gurus Latest Trades with NAS:UTHR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:UTHR is held by these investors
Total 4
United Therapeutics Corp Insider Transactions
No Available Data
News about NAS:UTHR
Total 0- 1